Skip to content
Friday, 20 November 2026
Inspire.News

Unveiling truth, one story at a time

Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last

Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last
Image: CNBC

The drugmaker cited strong demand for its blockbuster drugs as it upgraded peak sales forecasts for multiple sclerosis, leukemia, and cholesterol medicines.

Full story

Continue reading this story on CNBC, the publisher that reported it.

Read the full story at CNBC ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business

See all